WO1999040898A3 - Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect - Google Patents
Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect Download PDFInfo
- Publication number
- WO1999040898A3 WO1999040898A3 PCT/CA1999/000095 CA9900095W WO9940898A3 WO 1999040898 A3 WO1999040898 A3 WO 1999040898A3 CA 9900095 W CA9900095 W CA 9900095W WO 9940898 A3 WO9940898 A3 WO 9940898A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- action
- rapid onset
- drug formulations
- therapeutic effect
- sublingual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU24062/99A AU2406299A (en) | 1998-02-12 | 1999-02-11 | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7454898P | 1998-02-12 | 1998-02-12 | |
US60/074,548 | 1998-02-12 | ||
CA2,243,983 | 1998-09-17 | ||
CA 2243983 CA2243983A1 (en) | 1998-02-12 | 1998-09-17 | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999040898A2 WO1999040898A2 (en) | 1999-08-19 |
WO1999040898A3 true WO1999040898A3 (en) | 1999-11-04 |
Family
ID=25680401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1999/000095 WO1999040898A2 (en) | 1998-02-12 | 1999-02-11 | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2406299A (en) |
WO (1) | WO1999040898A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7191927B2 (en) | 2017-07-12 | 2022-12-19 | サムソン クリニカル プロプライエタリー リミテッド | Promoting hair growth and treating hair loss or excessive hair loss |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2355406A (en) * | 1999-10-23 | 2001-04-25 | Alkaloid Ad | A sub-lingual dosage form comprising a morphine salt |
ITRM20030288A1 (en) * | 2003-06-10 | 2004-12-11 | Valerio Cioli | SUBLINGUAL ADMINISTRATION OF NON STEROID INFLAMMATORY (NSAID) |
US9925139B2 (en) | 2004-04-22 | 2018-03-27 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
AU2006206252B2 (en) | 2005-01-19 | 2009-11-05 | Neurohealing Pharmaceuticals, Inc. | Methods and compositions for decreasing saliva production |
EP1810678A1 (en) | 2006-01-19 | 2007-07-25 | Holger Lars Hermann | Use of morphine and naloxone for drug substitution |
EP2026792A2 (en) * | 2006-05-19 | 2009-02-25 | Somaxon Pharmaceuticals, Inc. | Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia |
US20080058408A1 (en) | 2006-05-19 | 2008-03-06 | Rogowski Roberta L | Low-dose doxepin for treatment of sleep disorders in elderly patients |
CA2687118A1 (en) | 2006-05-19 | 2007-12-13 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
US20100179215A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
US20100179214A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
ITMI20061117A1 (en) * | 2006-06-09 | 2007-12-10 | Michele Bonanomi | A PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINI METHOD FOR ITS PREPARATION AND USES |
CA2693992C (en) | 2006-07-20 | 2017-01-31 | Somaxon Pharmaceuticals, Inc. | Methods of improving the pharmacokinetics of doxepin |
WO2008052139A2 (en) | 2006-10-25 | 2008-05-02 | Somaxon Pharmaceuticals, Inc. | Ultra low dose doxepin and methods of using the same to treat sleep disorders |
US20110077200A1 (en) | 2006-12-06 | 2011-03-31 | Somaxon Pharmaceuticals, Inc. | Combination therapy using low-dose doxepin for the improvement of sleep |
WO2008128115A2 (en) | 2007-04-13 | 2008-10-23 | Somaxon Pharmaceuticals, Inc. | Low-dose doxepin formulations |
FR2926722B1 (en) * | 2008-01-25 | 2010-09-03 | Substipharm Dev | APPROPRIATE PHARMACEUTICAL FORMULATION FOR THE PREPARATION OF ORODISPERSIBLE PRELOISOLONE TABLETS |
WO2011101734A2 (en) | 2010-02-22 | 2011-08-25 | Lupin Limited | Taste-masked powder for suspension compositions of methylprednisolone |
ES2773467T3 (en) | 2014-10-29 | 2020-07-13 | Samson Clinical Pty Ltd | Oral minoxidil for the treatment of telogen effluvium |
US20170216220A1 (en) * | 2016-02-03 | 2017-08-03 | Intelgenx Corp. | Loxapine film oral dosage form |
US9949934B1 (en) | 2016-10-20 | 2018-04-24 | Intelgenx Corp. | Device and method of treating conditions associated with neuroinflammation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1279214A (en) * | 1970-01-22 | 1972-06-28 | Forest Laboratories | Long-acting oral carrier |
EP0306422A1 (en) * | 1987-09-02 | 1989-03-08 | Medibrevex Sa | Galenical forms of 2-beta-mimetics for perlingual and sublingual administration |
EP0311540A1 (en) * | 1987-10-08 | 1989-04-12 | Medibrevex Sa | Galenical forms of corticoids for per- and sublingual administration, and their preparation process |
FR2640138A1 (en) * | 1988-12-13 | 1990-06-15 | Medibrevex | Process for obtaining dosage forms based on active pharmaceutical compounds for per- and sublingual administration |
WO1998002187A1 (en) * | 1996-07-11 | 1998-01-22 | Farmarc Nederland B.V. | Pharmaceutical composition containing acid addition salt of basic drug |
-
1999
- 1999-02-11 WO PCT/CA1999/000095 patent/WO1999040898A2/en active Application Filing
- 1999-02-11 AU AU24062/99A patent/AU2406299A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1279214A (en) * | 1970-01-22 | 1972-06-28 | Forest Laboratories | Long-acting oral carrier |
EP0306422A1 (en) * | 1987-09-02 | 1989-03-08 | Medibrevex Sa | Galenical forms of 2-beta-mimetics for perlingual and sublingual administration |
EP0311540A1 (en) * | 1987-10-08 | 1989-04-12 | Medibrevex Sa | Galenical forms of corticoids for per- and sublingual administration, and their preparation process |
FR2640138A1 (en) * | 1988-12-13 | 1990-06-15 | Medibrevex | Process for obtaining dosage forms based on active pharmaceutical compounds for per- and sublingual administration |
WO1998002187A1 (en) * | 1996-07-11 | 1998-01-22 | Farmarc Nederland B.V. | Pharmaceutical composition containing acid addition salt of basic drug |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7191927B2 (en) | 2017-07-12 | 2022-12-19 | サムソン クリニカル プロプライエタリー リミテッド | Promoting hair growth and treating hair loss or excessive hair loss |
Also Published As
Publication number | Publication date |
---|---|
WO1999040898A2 (en) | 1999-08-19 |
AU2406299A (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999040898A3 (en) | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect | |
DK0904055T3 (en) | Non-polar buccal spray or capsule | |
ITMI961152A0 (en) | THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF | |
CA2370565A1 (en) | Dermally applicable vitamin d-containing pharmaceutical compositions | |
WO2004043428A3 (en) | Buccal, polar and non-polar spray or capsule containing drugs for treating pain | |
AU1434000A (en) | Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption | |
WO2004035021A3 (en) | Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system | |
EP1419803A3 (en) | Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid | |
WO2004019912A3 (en) | Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer | |
WO2000003753A3 (en) | Microdisperse drug delivery systems | |
CA2411754A1 (en) | 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents | |
WO2003063800A8 (en) | 8-heteroaryl xanthine adenosine a2b receptor antagonists | |
HUP0003386A2 (en) | Use of crf antagonists for the preparation of pharmaceutical compositions treating depression, cardiovascular diseases | |
IL160222A0 (en) | Opioid agonist formulations with releasable and sequestered antagonist | |
WO2004019911A3 (en) | Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders | |
EP1247456A3 (en) | Palatable pharmaceutical compositions for companion animals | |
DE60120648D1 (en) | FORMULATIONS OF COPOLYMER 1 (GLATIRAMERACETATE) TO ORAL, NASAL AND PULMONARY ADMINISTRATION | |
BR0008228A (en) | Compositions of n-benzoyl staurosporine spontaneously dispersible | |
CA2312840A1 (en) | The use of polyols in combating yeast infection and polyol preparations for said use | |
EP0992240A4 (en) | Therapeutic agent for erection failure | |
EP0244083A3 (en) | Amino acid derivatives | |
AU2108500A (en) | Galenic formulation containing biotin | |
HUP0400553A2 (en) | Pharmaceutical compositions | |
EP0190891A3 (en) | Novel amino acid derivatives | |
WO1999012545A3 (en) | Medicaments containing acyclovir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |